The development and first validation of the manchester early morning symptoms index (MEMSI) for patients with COPD

Thorax

Volumn 70, Issue 8, 2015, Pages 757-763

  Garrow, Adam P ^a   Khan, Naimat ^a   Tyson, Sarah ^b   Vestbo, Jørgen ^c   Singh, Dave ^b   Yorke, Janelle ^a,b  

^a Medicines Evaluation Unit   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSTRUCT VALIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY FATIGUE SCALE; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE; HEALTH STATUS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MANCHESTER EARLY MORNING SYMPTOMS INDEX; MEDICAL RESEARCH COUNCIL DYSPNOEA SCALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RASCH ANALYSIS; RESPIRATORY TRACT DISEASE ASSESSMENT; ST. GEORGE RESPIRATORY QUESTIONNAIRE; SYMPTOM; TEST RETEST RELIABILITY; VALIDATION PROCESS; CIRCADIAN RHYTHM; DAILY LIFE ACTIVITY; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; PSYCHOMETRY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; UNITED KINGDOM; VALIDATION STUDY;

ACTIVITIES OF DAILY LIVING; AGED; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; FEMALE; GREAT BRITAIN; HUMANS; MALE; PSYCHOMETRICS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 84940873954     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2014-206410     Document Type: Article

References (26)

1. Kessler R, Partridge MR, Miravitlles M, et al. Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J 2011;37:264-72.
2. Omachi TA, Blanc PD, Claman DM, et al. Disturbed sleep among COPD patients is longitudinally associated with mortality and adverse COPD outcomes. Sleep Med 2012;13:476-83.
3. Roche N, Small M, Broomfield S, et al. Real world COPD: association of morning symptoms with clinical and patient reported outcomes. COPD J Chronic Obstr Pulm Dis 2013;10:679-86.
4. US Department of Health and Human Services Food and Drug Administration. Guidance for Industry Use in Medical Product Development to Support Labeling Claims Guidance for Industry. 2009. http://www.fda.gov/downloads/Drugs/ Guidances/UCM193282.pdf
5. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-65.
6. Katz S. Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc 1983;31:721-7.
7. Green J, Thorogood N. Qualitative Methods for Health Research. London: SAGE Publications Ltd, 2004.
8. Willis GB, Lessler JT. Question Appraisal System: QAS 99. National Cancer Institute, 1999.
9. Yorke J, Moosavi SH, Shuldham C, et al. Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax 2010;65:21-6.
10. Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J 2009;34:648-54.
11. Yorke J, Corris P, Gaine S, et al. EmPHasis-10: Development of a health-related quality of life measure in pulmonary hypertension. Eur Respir J 2014;43: 1106-13.
12. Tennant A, McKenna SP, Hagell P. Application of Rasch analysis in the development and application of quality of life instruments. Value Health 2004;7(Suppl 1): S22-6.
13. Yellen SB, Cella DF, Webster K, et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997;13:63-74.
14. Zigmond AS, Snaith RP. The hospital anxiety and depression scale (HADS). Acta Psychiatr Scand 1983;67:361-70.
15. Meguro M, Barley EA, Spencer S, et al. Development and validation of an improved, COPD-specific version of the St. George respiratory questionnaire. Chest 2007;132:456-63.
16. Doherty DE, Belfer FMH, Brunton FSA, et al. Chronic obstructive pulmonary disease: Consensus Recommendations for Early Diagnosis and Treatment. J Fam Pract 2006;55:1-8.
17. Altman D, Crc H. Practical statistics for medical research. London: Chapman & Hall, 1991.
18. Linacre J. Sample size and item calibration stability. Rasch Meas Trans 1994;7:28.
19. Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol 2005;193:103-13.
20. Duncan PW, Bode RK, Lai SM, et al. Rasch analysis of a new stroke-specific outcome scale: The stroke impact scale. Arch Phys Med Rehabil 2003;84:950-63.
21. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
22. Bestall J, Paul E, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581-6.
23. Jones PW, Brusselle G, Dal Negro RW, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med 2011;105:57-66.
24. Partridge MR, Karlsson N, Small IR. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey. Curr Med Res Opin 2009;25:2043-8.
25. Partridge MR, Miravitlles M, Ståhl E, et al. Development and validation of the capacity of daily living during the morning questionnaire and the global chest symptoms questionnaire in COPD. Eur Respir J 2010;36:96-104.
26. Jones P, Miravitlles M, van der Molen T, et al. Beyond FEV1 in COPD: a review of patient-reported outcomes and their measurement. Int J Chron Obstruct Pulmon Dis 2012;7:697-709.